ask="45.87"
ask_size="200"
average_daily_volume="406985"
bid="42.10"
bid_size="200"
book_value="14.89"
change="+1.58"
change_from_200_day_moving_average="-4.35"
change_from_50_day_moving_average="-3.08"
change_from_52_week_high="-15.17"
change_From_52_week_low="17.80"
change_in_percent="+3.57%"
close="45.81"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="46.00"
high_52_weeks="60.98"
last_trade_date="1/31/2017"
last_trade_price="45.81"
last_trade_size="30304"
last_trade_time="4:00pm"
low="43.20"
low_52_weeks="28.01"
market_capitalization="1.24B"
moving_average_200_day="50.16"
moving_average_50_day="48.89"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="43.92"
pe_ratio="5.12"
peg_ratio="0.32"
percent_change_from_200_day_moving_average="-8.67%"
percent_change_from_50_day_moving_average="-6.29%"
percent_change_from_52_week_high="-24.88%"
percent_change_from_52_week_low="+63.55%"
previous_close="44.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.97"
price_per_sales="3.11"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.16"
stock_exchange="NMS"
symbol="FPRX"
volume="316320"
weeks_range_52="28.01 - 60.98"
